FDA Pulls Zofran 32 mg due to Potential For Serious Cardiac Risks

No comment has been received.

If you are or represent the accused and would like to have your side of the story published here, we, in the interest of fairness, are happy to do so.

Please click here to submit your text along with contact info so that we can verify it.


Sincerely,
The Management
Online Legal Media


Return to FDA Pulls Zofran 32 mg due to Potential For Serious Cardiac Risks